Advancing Cancer Research Through Collaboration
Friends of Cancer Research (Friends) is working to accelerate policy change, support groundbreaking science, and deliver new therapies to patients quickly and safely.
About Friends

Who We Are,
What We Drive

Friends of Cancer Research drives collaboration among partners from every healthcare sector to power advances in science, policy, and regulation that speed life-saving treatments to patients.

  • Drug Development
  • Policy Research & Analysis
  • Diagnostic Development
  • Education & Advocacy
Circulating Tumor DNA (ctDNA)
ctDNA to Monitor Treatment Response (ctMoniTR) is a first of its kind partnership led by Friends of Cancer Research (Friends) to answer the question: Do changes in ctDNA reflect response to treatment?
Learn More
Statement from Friends of Cancer Research on the VALID Act
Friends supports advancing this vital legislation, which would enable uniform oversight of diagnostics.
Read More
COVID-19 Evidence Accelerator
The COVID-19 Evidence Accelerator provides a unique venue for organizations to gather and design quick turnaround queries and share their results.
Learn More
Bringing together patients and their advocates who wish to incorporate their insight into the regulatory process.
Learn More

Our Power of Collaboration

Publications and growing
Breakthrough therapy designations
Approved breakthrough therapies
Active partnerships

Get Involved

Join Friends by supporting our important work speeding lifesaving treatments to patients.